Credit Rating

Business

Twist Bioscience Powers Ahead: Q1 2026 Revenue Jumps 17%, Fueled by AI-Driven Discovery Boom

Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.

Feb 2, 2026

Business

Explosive Allegations: Justin Sun Accused of Orchestrating TRX 'Pump and Dump' via Binance Accounts

A woman identifying herself as Justin Sun's former partner has leveled serious market manipulation claims against the Tron founder, alleging he used employee-linked Binance accounts to inflate TRX's price during the 2017-2018 crypto boom before cashing out, leaving retail investors holding the bag.

Feb 2, 2026

Business

Cash Flow Alone Isn't Enough: Three High-Generating Stocks That Raise Investor Concerns

While robust cash generation is a hallmark of financial health, it doesn't guarantee stock outperformance. We examine three companies—PVH, Scorpio Tankers, and Amneal Pharmaceuticals—where strong cash flows are overshadowed by strategic challenges, raising red flags for discerning investors.

Feb 2, 2026

Business

Beyond the Hype: Separating Market Momentum from Sustainable Value

While several stocks have posted impressive short-term gains, a closer look reveals a divergence between fleeting catalysts and fundamental strength. We analyze one surging name with a solid foundation and two others where caution may be warranted.

Feb 2, 2026

Business

Danaher Forges Strategic Alliance with Automata, Accelerating AI-Powered Laboratory Automation

Danaher Corporation announces a strategic investment in Automata, aiming to integrate AI-ready automation systems with its extensive portfolio of instruments and reagents. The move signals a push to deliver comprehensive, data-driven lab solutions as the life sciences sector increasingly prioritizes efficiency and scalability.

Jan 31, 2026

Business

Avidbank Posts Strong Q4 Growth Amid Focus on Credit Management

Avidbank Holdings (AVBH) reported robust loan and deposit growth alongside an expanding net interest margin for Q4 2025, while management detailed plans to address a recent uptick in non-performing assets linked to specific construction and sponsor finance loans.

Jan 30, 2026

Business

Citi Doubles Down on AppLovin: Maintains Buy Rating with $820 Target, Citing E-Commerce Surge

Citigroup reaffirms its bullish stance on AppLovin (APP), highlighting the rapid adoption of its Axon platform by e-commerce clients and improved customer quality as key growth drivers, with a price target of $820.

Jan 30, 2026

Business

Sweetgreen Shares Slump Amid Growth Stock Sell-Off, Goldman Sachs Maintains Sell Rating

The fast-casual salad chain's stock fell sharply this week, pressured by a broader retreat in growth stocks and a reiterated sell call from Goldman Sachs, despite positive signals from the broader restaurant sector.

Jan 30, 2026

Business

Cavco Industries Posts Strong Q1 2026 Results on Surging Demand and Strategic Execution

Cavco Industries (CVCO) reported robust first-quarter fiscal 2026 earnings, with revenue climbing 9.5% year-over-year and operating profit jumping approximately 50%. The manufactured housing leader credited strategic production increases, improved pricing, and a rebound in its financial services segment for the strong performance, while also highlighting its pending acquisition of American Homestar.

Jan 30, 2026

Business

TD Cowen Trims Price Target on Canadian Pacific Kansas City, Maintains Buy Rating Amid Shifting Investor Focus

Analyst Jason Seidl lowered CP's target to C$112 from C$116, citing reasonable valuation post-KCS merger but noting headwinds from negative estimate revisions and investor capital flowing toward U.S. rail M&A opportunities.

Jan 30, 2026

Business

Goldman Sachs Slaps Sell Rating on iHeartMedia, Citing Valuation Fears After Stellar Run

Goldman Sachs downgrades iHeartMedia to Sell, warning that shifting audio consumption and ad trends threaten growth, even as the company's TikTok partnership aims to capture younger audiences.

Jan 30, 2026

Business

TD Cowen Stands By Alphatec (ATEC) With Buy Rating, Sees $20 Target Amid Coverage Shift

Despite a lowered price target following an analyst transition, TD Cowen maintains a bullish stance on Alphatec Holdings, citing undervalued growth drivers including a new regenerative bone graft partnership and a robust long-term revenue outlook.

Jan 30, 2026

Business

Meta's $135 Billion AI Bet Signals Accelerating Arms Race, With CoreWeave Poised to Capitalize

Meta Platforms' staggering capital expenditure forecast for 2026, heavily weighted toward AI infrastructure, underscores the intensifying tech investment cycle. Specialized cloud provider CoreWeave emerges as a likely key beneficiary, its fortunes tied to the hyperscaler spending spree.

Jan 30, 2026

Business

AI Data Surge Fuels Western Digital's Strong Q2, Drives High-Capacity Storage Demand

Western Digital's fiscal Q2 2026 results showcase robust growth, with revenue climbing 25% year-over-year to $3.0 billion. The company credits accelerating AI adoption for driving demand for its high-capacity nearline hard drives and advanced technologies like HAMR and UltraSMR.

Jan 30, 2026

Business

A Ponzi in the Parts Aisle: How First Brands' Founders Allegedly Engineered a $9 Billion Collapse

Federal prosecutors have charged the founders of the once-dominant auto parts supplier First Brands Group with orchestrating a massive, years-long fraud, alleging a scheme that misled lenders and ultimately led to the company's catastrophic bankruptcy, sending shockwaves through the industry.

Feb 2, 2026

Business

FDA Grants Breakthrough Status to Cogent Biosciences' GIST Combo Therapy, Accelerating Path to Market

Cogent Biosciences secures a key FDA Breakthrough Therapy Designation for its bezuclastinib-sunitinib combination in advanced GIST, following promising Phase 3 data that showed a halving of disease progression risk.

Feb 2, 2026

Business

Enterprise Financial Beats Q4 Estimates on Margin Strength, Deposit Growth

Enterprise Financial Services Corp. (EFSC) reported fourth-quarter revenue that surpassed analyst forecasts, driven by net interest income expansion and robust deposit growth. The regional bank's results were bolstered by recent branch acquisitions and disciplined pricing, though investors are now watching how it navigates potential rate cuts and credit quality.

Feb 2, 2026

Business

O'Donnell Financial Bets $6.8 Million on AAA CLO ETF, Signaling Confidence in Income Strategy

A major stake increase by O'Donnell Financial in the iShares AAA CLO Active ETF (CLOA) highlights institutional interest in high-grade, actively managed securitized credit as a source of yield in a complex rate environment.

Feb 2, 2026

Business

Arbor Realty Trust's Tax Break for 2025 Dividends Fails to Ease Deepening Analyst Pessimism

While Arbor Realty Trust offers shareholders clarity on favorable tax treatment for 2025 dividends, analysts remain focused on a deteriorating earnings outlook and a 'Strong Sell' rating, casting doubt on the stock's near-term prospects.

Feb 2, 2026

Business

FICO's Stock Stumbles: A Buying Opportunity or a Sign of Overvaluation?

Fair Isaac Corporation (FICO), the analytics software giant behind the ubiquitous credit score, has seen its shares retreat from multi-year highs. This pullback has investors debating whether the dip presents a rare entry point or signals that the stock's premium valuation is finally facing a reality check.

Jan 31, 2026